Mesalamine
NDC 70954-301, Mesalamine, suspension, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-301
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Route
- RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215269
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-301 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE4 g/60mL
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-301-20 | 70954030120 | 7 BOTTLE in 1 CARTON (70954-301-20) / 60 mL in 1 BOTTLE (70954-301-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/485ed763-976e-4410-a401-7ff762a931b3NADAC price for package 70954030120
GET /v1/drugs/nadac/70954030120
Use it
Look up 70954-301 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-301 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.